PharVision Advisers LLC purchased a new position in Itron, Inc. (NASDAQ:ITRI - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,859 shares of the scientific and technical instruments company's stock, valued at approximately $300,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in ITRI. Captrust Financial Advisors grew its stake in shares of Itron by 6.3% in the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock worth $233,000 after buying an additional 128 shares during the last quarter. CoreCap Advisors LLC boosted its stake in Itron by 25.5% during the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock valued at $67,000 after purchasing an additional 125 shares during the last quarter. Driehaus Capital Management LLC boosted its stake in Itron by 2.7% during the 4th quarter. Driehaus Capital Management LLC now owns 342,427 shares of the scientific and technical instruments company's stock valued at $37,181,000 after purchasing an additional 9,107 shares during the last quarter. Deutsche Bank AG boosted its stake in Itron by 6.4% during the 4th quarter. Deutsche Bank AG now owns 260,360 shares of the scientific and technical instruments company's stock valued at $28,270,000 after purchasing an additional 15,717 shares during the last quarter. Finally, Ethic Inc. boosted its stake in Itron by 21.2% during the 4th quarter. Ethic Inc. now owns 3,846 shares of the scientific and technical instruments company's stock valued at $418,000 after purchasing an additional 673 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company's stock.
Insiders Place Their Bets
In other news, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the sale, the senior vice president directly owned 14,396 shares of the company's stock, valued at approximately $1,803,962.76. The trade was a 3.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Donald L. Reeves III sold 547 shares of Itron stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $68,544.57. Following the completion of the sale, the senior vice president directly owned 19,604 shares in the company, valued at $2,456,577.24. This trade represents a 2.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 12,073 shares of company stock valued at $1,480,880. Insiders own 1.51% of the company's stock.
Itron Price Performance
NASDAQ:ITRI traded down $0.33 on Monday, reaching $120.12. 479,782 shares of the company's stock traded hands, compared to its average volume of 495,511. The stock has a 50-day simple moving average of $129.10 and a 200-day simple moving average of $117.07. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $140.04. The firm has a market cap of $5.49 billion, a PE ratio of 20.53, a P/E/G ratio of 0.66 and a beta of 1.46. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48.
Itron (NASDAQ:ITRI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. During the same period in the previous year, the business earned $1.21 earnings per share. The business's revenue was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Equities research analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.
Analyst Upgrades and Downgrades
ITRI has been the topic of several recent analyst reports. Wall Street Zen upgraded Itron from a "hold" rating to a "buy" rating in a research note on Saturday, August 2nd. JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and increased their target price for the company from $128.00 to $145.00 in a research note on Thursday, July 31st. TD Cowen increased their target price on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, June 20th. Guggenheim reissued a "buy" rating and issued a $155.00 target price (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Finally, Roth Capital increased their target price on Itron from $130.00 to $150.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $136.55.
View Our Latest Report on Itron
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.